Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Volunteers
Health Professionals
What is the purpose of this trial?
The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.
We need both 40 matched Healthy controls for a single fMRI, as well as 80 Unmedicated participants with OCD for a randomized, double blind OCD treatment trial with 4 fMRI scans over 18 weeks.
Please email OCD.Research@yale.edu or call and leave a message at 1-855-OCD-YALE (1-855-623-9253).- Trial withBrain and Behavior Research Foundation, Yale University School of Medicine, Nancy Taylor Foundation for Chronic Diseases, Inc., and National Institute of Mental Health (NIMH)
- Ages18 years - 65 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated09/17/2024
- Study HIC#2000023688